Swiss drug maker Roche said its investigational drug for advanced skin cancer - RG7204 - showed significant survival benefit in a late stage study.
Apple reported another record quarter, with revenue hitting $26.74 billion, above the most optimistic Wall Street estimates of about $25 billion. The iconic technology company posted $6 billion in profit, or $6.43 per share.
Apple is set to report earnings today, and analysts are expecting revenue to jump to as much as $24 billion, a rise of 55 percent over the year-ago quarter. But the thought of the company without Steve Jopbs is casting a pall over the good news.
Apple Inc Chief Executive Steve Jobs has been granted medical leave to concentrate on his health, he said on Monday.
Annette Bening, who played a lesbian mother in The Kids Are All Right, and Christian Bale, who portrayed a drug-addicted boxer in The Fighter, won Golden Globe trophies on Sunday.
Lance Armstrong is not losing any sleep over a U.S. federal investigation into allegations of doping in his team, the seven-times Tour de France champion said on Saturday ahead of his final international race.
The pep talk and horoscope agonies surrounding the so-called new zodiac sign Ophiuchus is unwarranted and misplaced. First and foremost there is nothing exactly new about Ophiuchus, the 13th zodiac sign - it was revealed and discussed years ago. Second, the whole exercise of looking up to the celestial position to know one' fate is just another anomaly in an otherwise scientific age. And finally, if you still think stars and their position do matter to what happens in your life, horos...
The new sign Ophiuchus will cover those born between Nov. 29 and Dec. 17 while Sagittarius will move into the 13th position covering from Dec. 17 to Jan. 20.
Apple has recommended its shareholders to vote against the demand for a CEO succession plan at the Annual Meeting of shareholders in February.
The world is greeting the news with reserve as John lost his wife to cancer just a month back
The top pre-market NASDAQ stock market gainers are: XOMA, ATP Oil & Gas, Sonic, DryShips, Qiao Xing Universal Resources, Melco Crown Entertainment, Star Scientific, Logitech International, Microvision, and Asia Entertainment & Resources.
For 106 years, Times Square has been the center of worldwide attention on New Year's Eve, ever since the owners of One Times Square began Ball Lowering celebration in 1907, and this tradition is now a universal symbol of welcoming the New Year.
Odd science claims made by various celebrities - about diets, cancer, reabsorbing sperm, hologram bracelets and more - make no scientific sense, according to a campaign group.
Polychlorinated biphenyls, or PCBs, are man-made chemicals that have been recognized for the last 30 years to be toxic and potentially carcinogenic. They can affect the immune system, reproductive system, nervous system and endocrine system and, if they build up in the body long enough, they can cause cancer.
The top pre-market NASDAQ stock market losers are: Subaye, Oncothyreon, American Science & Engineering, ARM Holdings, Tesla Motors, XOMA, CROCS, Micron Technology, ASML Holding, and Sycamore Networks.
Rodman & Renshaw initiated coverage of Soligenix Inc. (OTC: SNGX) with a Market Outperform rating and a $0.90 price target, saying shares of the late-stage biopharmaceutical company are poised to run higher on outlook for its orBec (oral beclomethasone) lead product.
The top after-market NASDAQ stock market losers are: Penford, Pacific Biosciences of California, Netlist, Micron Technology, Copano Energy, SMTC, Coldwater Creek, Avanir Pharmaceuticals, ChinaCast Education, Oncothyreon, and Gilead Sciences.
The top pre-market NASDAQ stock market gainers are: LaserCard, Martek Biosciences, Adobe Systems, Incyte, Magic Software Enterprises, AudioCodes, Power-One, Netflix, ZST Digital Networks, and SanDisk.
The top after-market NASDAQ stock market gainers are: LaserCard, Incyte, Adobe Systems, Sonus Networks, Myriad Genetics, YRC Worldwide, SciClone Pharmaceuticals, Perficient, MannKind, and Web.com Group.
A chemical which, in high concentrations, is likely to cause cancer and irritates the respiratory system and skin has been found in tap water in 31 of 35 American cities, according to a new study.
The top pre-market NASDAQ stock market gainers are: CyberDefender, Lattice Semiconductor, support.com, Cost Plus, Enzon Pharmaceuticals, Cogo Group, Sky-mobi, LJ International, Entropic Communications, and Novavax.
The top after-market NASDAQ stock market losers are: SciClone Pharmaceuticals, Tower Bancorp, Capitol Federal Financial, Orthofix International, Pulaski Financial, Energy Recovery, Energy Conversion Devices, China Ritar Power, EZchip Semiconductor, and Hercules Offshore.